Health
Oncology Clinic Chain Amethyst Plans Expansion To Germany And France In 2014
The shareholders of oncology clinic chain Amethyst opened a clinic in Krakow (Poland) last October and plan to launch two similar units in Germany and France in 2014.
Antibiotice Proposes RON15.4M Dividend For 2013
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) proposes a dividend payment of 15.4 million lei (EUR3.44 million) from the 2013 profits, the company said in a call to its shareholders...
GSK Romania Has New GM Starting April 1
Barbara Cygler has been appointed general manager of GlaxoSmithKline’s Romanian subsidiary and will take over the new position starting April 1, 2014.
Sarantis Sales In Romania Up 4.35% To EUR36M In 2013
Greek group Sarantis, owner of cosmetics producer Elmiplant, said Thursday it registered sales of EUR35.86 million in Romania in 2013, up 4.35% from EUR34.37 million in 2012.
Fate Of GSK's Europharm Plant in Brasov Still Undecided
The deadline GlaxoSmithKline (GSK) set for finding a buyer for its pharmaceutical plant Europharm in Brasov expires at the end of the month.
Abbott Romania Seeks Partnerships With Romanian Drug Makers
Abbott Products Romania is interested in developing partnerships with domestic drug makers and talks are ongoing, said company general manager Adrian Grecu.
Biofarm 2014 Profit Seen Down 15% At RON21.7M
Romanian pharmaceuticals company Biofarm (BIO.RO) targets a net profit of 21.7 million lei (EUR4.8 million) for 2014, down 15% on the year, and RON128 million sales (EUR28.4 million), up 9%...
Advent Sold Labormed For $33M, 20% Of Acquisition Price
Investment fund Advent sold Romanian generic drug producer Labormed last year to U.S. pharmaceutical company Alvogen for $33 million (EUR24 million), less than 20% of the acquisition price p...
Turkey’s Acibadem Mulls Opening Hospital In Romania
Acibadem group of Turkey, which operates a network of 17 general hospitals and 13 clinics, is likely to enter the Romanian market directly by opening a hospital modeled after its units in Tu...